The IL-6/STAT3 signaling pathway induces a loss of muscle mass in experimental cachexia models via two pathways, where on the one hand, STAT3 phosphorylation leads to activation of hepatic acute phase protein gene expression [40]. Here, STAT3 is linked to Cachexia.